Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Human Papillomavirus-Related Cervical Carcinoma × Tetanus Toxoid × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Papillomavirus Infections 1 Human Papillomavirus-Related Cervical Carcinoma 1 Advanced Fallopian Tube Carcinoma 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 2 adacel 1 Tetanus Toxoid 1 Human Papillomavirus Recombinant Vaccine nonavalent 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Diphtheria-Tetanus-acellular Pertussis Vaccines 1 Diphtheria Toxoid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05237947 2026-03-19

PRISMA

National Cancer Institute (NCI)

Phase 4 Active not recruiting

Human Papillomavirus-Related Cervical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡